AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falini, A.
Right arrow Articles by Scotti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falini, A.
Right arrow Articles by Scotti, G.

American Journal of Neuroradiology, Vol 19, Issue 2 223-229, Copyright © 1998 by American Society of Neuroradiology


ARTICLES

Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability

A Falini, G Calabrese, M Filippi, D Origgi, S Lipari, B Colombo, G Comi and G Scotti
Department of Neuroradiology, Scientific Institute San Raffaele Hospital, University of Milan, Italy.

PURPOSE: We determined the clinical utility of proton MR spectroscopy in defining the extent of disability in benign versus secondary- progressive multiple sclerosis (MS). METHODS: Thirty patients with clinically definite MS, including 16 patients with benign MS and 14 with secondary-progressive MS, and a group of 13 healthy volunteers were studied with combined stimulated-echo acquisition mode proton MR spectroscopy and MR imaging (all patients received contrast material). RESULTS: Acute enhancing lesions of benign and secondary-progressive MS were characterized by a reduction in N-acetylaspartate (NAA)/choline and NAA/creatine and an increase in inositol compounds/creatine as compared with normal white matter. Such variations were also detected in chronic unenhancing lesions in patients with secondary-progressive MS, although they were not found in chronic unenhancing lesions in patients with benign MS. Chronic lesions of the two forms of the disease have significative differences in NAA and inositol signals. CONCLUSION: Proton MR spectroscopy is able to show metabolic changes occurring in the white matter of patients with MS. Such changes differ according to the phase (acute versus chronic) and the clinical form (benign versus secondary-progressive) of the disease.


This article has been cited by other articles:


Home page
NeurologyHome page
M. P. Amato, E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, et al.
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis
Neurology, August 26, 2008; 71(9): 632 - 638.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Strasser-Fuchs, C. Enzinger, S. Ropele, M. Wallner, and F. Fazekas
Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
Multiple Sclerosis, March 1, 2008; 14(2): 205 - 211.
[Abstract] [PDF]


Home page
BrainHome page
N. De Stefano, M. Battaglini, M. L. Stromillo, V. Zipoli, M. L. Bartolozzi, L. Guidi, G. Siracusa, E. Portaccio, A. Giorgio, S. Sorbi, et al.
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis
Brain, August 1, 2006; 129(8): 2008 - 2016.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
A Castriota-Scanderbeg, F Fasano, M Filippi, and C Caltagirone
T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis
Multiple Sclerosis, October 1, 2004; 10(5): 556 - 561.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. N. Whitaker, J. S. Wolinsky, P. A. Narayana, A. A. Bartolucci, J. H. Noseworthy, F. D. Lublin, A. Linde, P. Gjorstrup, H. C. Sullivan, and for the North American Linomide Investigators
Relationship of Urinary Myelin Basic Protein-Like Material With Cranial Magnetic Resonance Imaging in Advanced Multiple Sclerosis
Arch Neurol, January 1, 2001; 58(1): 49 - 54.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Filippi
Enhanced magnetic resonance imaging in multiple sclerosis
Multiple Sclerosis, October 1, 2000; 6(5): 320 - 326.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
I. Mader, W. Roser, L. Kappos, G. Hagberg, J. Seelig, E. W. Radue, and W. Steinbrich
Serial Proton MR Spectroscopy of Contrast-enhancing Multiple Sclerosis Plaques: Absolute Metabolic Values over 2 Years during a Clinical Pharmacological Study
AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1220 - 1227.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Lovas, N. Szilagyi, K. Majtenyi, M. Palkovits, and S. Komoly
Axonal changes in chronic demyelinated cervical spinal cord plaques
Brain, February 1, 2000; 123(2): 308 - 317.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Tortorella, B. Viti, M. Bozzali, M. P. Sormani, G. Rizzo, M. F. Gilardi, G. Comi, and M. Filippi
A magnetization transfer histogram study of normal-appearing brain tissue in MS
Neurology, January 11, 2000; 54(1): 186 - 186.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Tourbah, J. L. Stievenart, O. Gout, B. Fontaine, R. Liblau, C. Lubetzki, E. A. Cabanis, and O. Lyon-Caen
Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis
Neurology, September 1, 1999; 53(5): 1091 - 1091.
[Abstract] [Full Text]


Home page
Mult SclerHome page
M. Filippi, C. Tortorella, and M. Bozzali
Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques
Multiple Sclerosis, August 1, 1999; 5(4): 273 - 282.
[Abstract] [PDF]